These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 687104)

  • 1. Management of familial breast cancer. II. Case reports, pedigrees, genetic counseling, and team concept.
    Lynch HT; Harris RE; Organ CH; Lynch JF
    Arch Surg; 1978 Sep; 113(9):1061-7. PubMed ID: 687104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of familial breast cancer. I. Biostatistical-genetic aspects and their limitations as derived from a familial breast cancer resource.
    Lynch HT; Harris RE; Organ CH; Lynch JF
    Arch Surg; 1978 Sep; 113(9):1053-8. PubMed ID: 687103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling, familial breast cancer, and the surgeon's responsibility.
    Lynch HT; Albano WA; Lynch JF
    Plast Reconstr Surg; 1980 Aug; 66(2):303-10. PubMed ID: 7403319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.
    Speight B; Tischkowitz M
    J Genet Couns; 2017 Dec; 26(6):1173-1178. PubMed ID: 28780755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multidisciplinary management of a family with epithelial ovarian cancer.
    Cruickshank DJ; Haites N; Anderson S; Matheson H; Hall MH; Milner B; Ah-See A; Gunn I; Eremin O; Gilbert F
    Br J Obstet Gynaecol; 1992 Mar; 99(3):226-31. PubMed ID: 1606122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.
    Morris KT; Johnson N; Krasikov N; Allen M; Dorsey P
    Am J Surg; 2001 May; 181(5):431-3. PubMed ID: 11448436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring family relationships in cancer risk counseling using the genogram.
    Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer EJ; Verhoog LC; Brekelmans CT; Seynaeve C; Tilanus-Linthorst MM; Wagner A; Dukel L; Devilee P; van den Ouweland AM; van Geel AN; Klijn JG
    Lancet; 2000 Jun; 355(9220):2015-20. PubMed ID: 10885351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic counseling in familial breast cancer].
    Pichert G
    Ther Umsch; 2008 Apr; 65(4):235-41. PubMed ID: 18622917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological aspects of monitoring high risk women for breast cancer.
    Lynch HT; Lynch J; Conway T; Severin M
    Cancer; 1994 Aug; 74(3 Suppl):1184-92. PubMed ID: 8039155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial breast and ovarian cancers.
    Arai M; Utsunomiya J; Miki Y
    Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project.
    Fries MH; Holt C; Carpenter I; Carter CL; Daniels J; Flanagan J; Murphy K; Hailey BJ; Martin L; Hume R; Hudson G; Cadman M; Weatherly R; Nunes ME
    Mil Med; 2002 Feb; 167(2):93-8. PubMed ID: 11873549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management updates for women with a BRCA1 or BRCA2 mutation.
    Nusbaum R; Isaacs C
    Mol Diagn Ther; 2007; 11(3):133-44. PubMed ID: 17570734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
    Scheuer L; Kauff N; Robson M; Kelly B; Barakat R; Satagopan J; Ellis N; Hensley M; Boyd J; Borgen P; Norton L; Offit K
    J Clin Oncol; 2002 Mar; 20(5):1260-8. PubMed ID: 11870168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
    Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
    McDonnell SK; Schaid DJ; Myers JL; Grant CS; Donohue JH; Woods JE; Frost MH; Johnson JL; Sitta DL; Slezak JM; Crotty TB; Jenkins RB; Sellers TA; Hartmann LC
    J Clin Oncol; 2001 Oct; 19(19):3938-43. PubMed ID: 11579114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylactic surgery of mammary and ovarian carcinoma].
    Lux MP; Bani MR; Fasching PA; Beckmann MW
    Chirurg; 2005 Dec; 76(12):1145-54. PubMed ID: 16237564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.